Skip to main navigation
Skip to search
Skip to main content
Sort by
Medicine and Dentistry
COVID-19
55%
Cerebellar Ataxia
41%
Magnetic Resonance Imaging
32%
Sarcoma
27%
Amyotrophic Lateral Sclerosis
27%
Sjoegren Syndrome
27%
Nitrous Oxide
27%
Noninvasive Ventilation
27%
Ethnic Minority Group
27%
Severe Acute Respiratory Syndrome Coronavirus 2
27%
Clinical Neuroscience
27%
Infection
27%
Ethnic Disparity
27%
Patient Selection
27%
Disorders of Mitochondrial Functions
27%
Case-Control Study
27%
Rituximab
27%
Myasthenia gravis
27%
Trigeminal Neuralgia
18%
Family History
18%
Myoclonus
18%
Adverse Event
17%
Symptom
13%
Recreational Drug
13%
Observational Study
13%
Lower Limb
13%
Potential Barrier
13%
Paresthesia
13%
Methylmalonic Acid
13%
Awareness
13%
Cyanocobalamin
13%
Ataxic Gait
13%
Slurred Speech
13%
Neurologic Disease
13%
Ethnic Groups
13%
Neurological Complication
13%
Upper Limb
13%
Subacute Combined Degeneration of Spinal Cord
13%
Respiratory Failure
13%
Arm
10%
Steroid Treatment
10%
Infusion
9%
Diseases
9%
Vertigo
9%
Motor Neuron Disease
9%
Mixed Connective Tissue Disease
9%
Hemifacial Spasm
9%
Stiff Person Syndrome
9%
Skew Deviation
9%
Facial Nerve Paralysis
9%
Neuroscience
Myasthenia gravis
72%
Ataxia
55%
Azathioprine
36%
Magnetic Resonance Imaging
36%
Rituximab
32%
Dysarthria
27%
Brainstem
27%
Sjogren's Syndrome
27%
Posterior Cranial Fossa
27%
Hydrocephalus
27%
Amyotrophic Lateral Sclerosis
27%
Hypertension
27%
Lymphocyte
27%
Myoclonus
22%
Trigeminal Neuralgia
18%
Intravenous Immunoglobulin
18%
Immunosuppressive Drug
17%
Warfarin
13%
Cerebral Peduncle
13%
Fourth Ventricle
13%
Cerebellar Hemisphere
13%
Headache
13%
Congenital Disorder
13%
Methotrexate
13%
Pons
13%
Heparin
13%
Lateral Ventricle
13%
Differential Diagnosis
13%
Oligoclonal Band
13%
Mitochondrial DNA
13%
Autoimmune Disease
13%
Vitamin E
13%
Fragile X Syndrome
13%
Cognitive Disorders
13%
Spinocerebellar Ataxia
13%
Epileptic Absence
13%
Tonic-Clonic Seizure
13%
Statin
13%
ACE Inhibitor
13%
B Cell
13%
Exon
9%
Nonsense Mutation
9%
Stiff Person Syndrome
9%
Cyclophosphamide
9%
Optic Neuritis
9%
Diplopia
9%
DNA Sequencing
9%
Motor Neuron Disease
9%
Electromyography
9%
Pelvis
9%
Pharmacology, Toxicology and Pharmaceutical Science
Myasthenia gravis
100%
Rituximab
55%
Azathioprine
55%
Side Effect
48%
Mycophenolic Acid
48%
Methotrexate
41%
Case-Control Study
27%
Adverse Event
21%
Immunosuppressive Agent
20%
Biosimilar Agent
15%
Disease Severity
13%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
13%
Dipeptidyl Carboxypeptidase Inhibitor
13%
Tolerability
9%
Randomized Controlled Trial
5%